The investment is a booster shot to South Africa’s ailing manufacturing sector. The move is part of Pfizer’s partnership with the Biovac Institute.
“We have been working with Biovac to get the site up and running so we can start manufacturing the pneumococcal vaccine, between one and three million doses annually. It is really to vaccinate children as part of the expanded programme for immunisation in South Africa,” Van der Loo said.“This is one of the two sites outside the normal multinational company network chosen to manufacture the Covid-19 vaccine.
이 소식을 빠르게 읽을 수 있도록 요약했습니다. 뉴스에 관심이 있으시면 여기에서 전문을 읽으실 수 있습니다. 더 많은 것을 읽으십시오:
Vaccines are no cure. The Oligarchs orchestrated this long ago for stupid people all over the world to follow the lie, mass murder. This is BS!
Africa does not need them.